Schrödinger, Inc. - Schrödinger Announces Multi-Target …
2 days ago · Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties Expanded multi-year software agreement enables technology deployment at significant scale across Novartis’s global research organization Schrödinger to host third quarter 2024 financial results webcast today at 8:00 a.m. ET Schrödinger, Inc. (Nasdaq ...
Schrödinger Announces Multi-Target Collaboration and …
2 days ago · NEW YORK, November 12, 2024--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a research collaboration and license agreement with Novartis to advance multiple development ...
Schrödinger Announces Multi-Target Collaboration and …
2 days ago · Under the terms of the agreement, Novartis will pay Schrödinger $150 million upfront, and Schrödinger will also be eligible to receive up to $892 million in research, development and regulatory ...
Novartis pays Schrödinger $150M to form drug discovery pact
2 days ago · Schrödinger is in line to receive up to $892 million in R&D and regulatory milestones plus $1.38 billion in commercial payouts and royalties on net sales for each product commercialized by Novartis.
Schrödinger Announces Multi-Target Collaboration and
2 days ago · Under the terms of the agreement, Novartis will pay Schrödinger $150 million upfront, and Schrödinger will also be eligible to receive up to $892 million in research, development and regulatory ...
Schrödinger enters collaboration pact with Novartis worth up to …
2 days ago · Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion Schrödinger to receive $150 million upfront plus up to $2.3 billion in milestone and royalty ...
Schrödinger Announces Multi-Target Collaboration and …
2 days ago · Schrödinger to host third quarter 2024 financial results webcast today at 8:00 a.m. ET. NEW YORK--(BUSINESS WIRE)--Nov. 12, 2024-- Schrödinger, Inc. (Nasdaq: SDGR) today announced a research collaboration and license agreement with Novartis to advance multiple development candidates into Novartis’s portfolio for further development. The ...
Schrödinger Reports Third Quarter 2024 Financial Results
2 days ago · Schrödinger to Receive $150 Million Upfront for New Multi-Target Collaboration with Novartis. Third Quarter Total Revenue of $35.3 Million, Software Revenue of $31.9 Million
Schrödinger's stock soars 9% as it enters collaboration pact with ...
2 days ago · Schrödinger Inc.'s stock (SDGR) soared 9% early Tuesday, after the company said it has entered a multi-year collaboration agreement with Swiss pharma Novartis AG (CH:NOVN) (NVS), under which it ...
Schrödinger Reports Third Quarter 2024 Financial Results
2 days ago · Schrödinger to Receive $150 Million Upfront for New Multi-Target Collaboration with Novartis. Third Quarter Total Revenue of $35.3 Million, Software Revenue of $31.9 Million. Updates 2024 Financial Guidance. ... Novartis will pay Schrödinger $150 million upfront, and Schrödinger will also be eligible to receive up to $892 million in research ...
- Some results have been removed